Feberwee A, Landman W J M, von Banniseht-Wysmuller Th, Klinkenberg D, Vernooij J C M, Gielkens A L J, Stegeman J A
Animal Health Service, Deventer, the Netherlands.
Avian Pathol. 2006 Oct;35(5):359-66. doi: 10.1080/03079450600924226.
The effect of a live Mycoplasma gallisepticum vaccine on the horizontal transmission of this Mycoplasma species was quantified in an experimental animal transmission model in specific pathogen free White Layers. Two identical trials were performed, each consisting of two experimental groups and one control group. The experimental groups each consisted of 20 birds 21 weeks of age, which were housed following a pair-wise design. One group was vaccinated twice with a commercially available live attenuated M. gallisepticum vaccine, while the other group was not vaccinated. Each pair of the experimental group consisted of a challenged chicken (10(4) colony-forming units intratracheally) and a susceptible in-contact bird. The control group consisted of 10 twice-vaccinated birds housed in pairs and five individually housed non-vaccinated birds. The infection was monitored by serology, culture and quantitative polymerase chain reaction. The vaccine strain and the challenge strain were distinguished by a specific polymerase chain reaction and by random amplified polymorphic DNA analysis. In both experiments, all non-vaccinated challenged chickens and their in-contact 'partners' became infected with M. gallisepticum. In the vaccinated challenged and corresponding in-contact birds, a total of 19 and 13 chickens, respectively, became infected with M. gallisepticum. Analysis of the M. gallisepticum shedding patterns showed a significant effect of vaccination on the shedding levels of the vaccinated in-contact chickens. Moreover, the Cox Proportional Hazard analysis indicated that the rate of M. gallisepticum transmission from challenged to in-contact birds in the vaccinated group was 0.356 times that of the non-vaccinated group. In addition, the overall estimate of R (the average number of secondary cases infected by one typical infectious case) of the vaccinated group (R = 4.3, 95% confidence interval = 1.6 to 49.9) was significantly lower than that of the non-vaccinated group (R = infinity, 95% confidence interval = 9.9 to infinity). However, the overall estimate of R in the vaccinated group still exceeded 1, which indicates that the effect of the vaccination on the horizontal transmission M. gallisepticum is insufficient to stop its spread under these experimental conditions.
在无特定病原体的白来航蛋鸡实验动物传播模型中,对鸡毒支原体活疫苗对该支原体水平传播的影响进行了量化。进行了两项相同的试验,每项试验包括两个实验组和一个对照组。实验组每组由20只21周龄的鸡组成,采用成对设计饲养。一组用市售的鸡毒支原体活减毒疫苗进行两次接种,而另一组未接种疫苗。实验组的每对鸡由一只受攻击鸡(气管内接种10⁴ 菌落形成单位)和一只易感染的接触鸡组成。对照组由10只成对饲养的两次接种疫苗的鸡和5只单独饲养的未接种疫苗的鸡组成。通过血清学、培养和定量聚合酶链反应监测感染情况。通过特异性聚合酶链反应和随机扩增多态性DNA分析区分疫苗株和攻击株。在两项实验中,所有未接种疫苗的受攻击鸡及其接触“伙伴”均感染了鸡毒支原体。在接种疫苗的受攻击鸡和相应的接触鸡中,分别有19只和13只鸡感染了鸡毒支原体。对鸡毒支原体排毒模式的分析表明,接种疫苗对接种疫苗的接触鸡的排毒水平有显著影响。此外,Cox比例风险分析表明,接种疫苗组中鸡毒支原体从受攻击鸡传播到接触鸡的速率是未接种疫苗组的0.356倍。此外,接种疫苗组的R(一个典型感染病例感染的二代病例平均数量)总体估计值(R = 4.3,95%置信区间 = 1.6至49.9)显著低于未接种疫苗组(R = ∞,95%置信区间 = 9.9至∞)。然而,接种疫苗组的R总体估计值仍超过1,这表明在这些实验条件下,接种疫苗对鸡毒支原体水平传播的影响不足以阻止其传播。